Information Provided By:
Fly News Breaks for September 5, 2019
GBT
Sep 5, 2019 | 11:04 EDT
Empire analyst Cathy Reese raised her price target on shares of Global Blood Therapeutics to $68 from $58 after the FDA accepted its voxelotor new drug application filing for priority review and has no plans to hold an Advisory Committee meeting.
News For GBT From the Last 2 Days
There are no results for your query GBT